A Study of RO5045337 [RG7112] in Patients With Hematologic Neoplasms.

Clinical trial NCT00623870 · COMPLETED

Trial details

NCT number: NCT00623870
Sponsor: Hoffmann-La Roche
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Hematologic Neoplasms

Start date: 2008-05-01
Primary completion: 2012-11-01
Enrollment: 116

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.